What they were paid
Prelude Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $57,500 | — | $28,533 | — | $86,033 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prelude Therapeutics Inc DEF 14A filed April 29, 2026, accession 0001193125-26-191532, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Prelude Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair)
The rest of the Prelude Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Katina Dorton | Independent Director | $77,564 |
| Krishna Vaddi | Director | $0 |
| Martin Babler | Independent Director | $78,533 |
| Paul A. Friedman | Independent Director | $102,533 |
| Paul Scherer | Independent Director | $81,566 |
| Victor Sandor | Independent Director | $194,528 |
The full Prelude Therapeutics compensation record
free company briefThis page is one director within Prelude Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat